Showing results (411-420 of 429) with videos related to
Sort By:
Pageof 43
Journal of Pain and Symptom Management|February 1, 2014
Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future developmentShirley H Bush, Salmaan Kanji, José L Pereira, et al.The Lancet. Respiratory Medicine|October 1, 2025
Morphine for chronic breathlessness (MABEL) in the UK: a multi-site, parallel-group, dose titration, double-blind, randomised, placebo-controlled trialMiriam J Johnson, Bronwen Williams, Catriona Keerie, et al.ESC Heart Failure|August 8, 2019
Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo-controlled trialMiriam J Johnson, Sarah Cockayne, David C Currow, et al.Journal of Pain and Symptom Management|February 23, 2025
Design Considerations for Medicinal Cannabis Clinical Trials in People Receiving Palliative CareValentina Razmovski-Naumovski, Jennifer H Martin, Richard Chye, et al.Plos One|May 17, 2023
Phase II, double blind, placebo controlled, multi-site study to evaluate the safety, feasibility and desirability of conducting a phase III study of anamorelin for anorexia in people with small cell lung cancer: A study protocol (LUANA trial)Mariana S Sousa, Peter Martin, Miriam J Johnson, et al.BMC Palliative Care|October 30, 2025
Toward a comprehensive research agenda: exploring the health economics of palliative care in AustraliaChris Schilling, Cate Bailey, Katharina Merollini, et al.The New England Journal of Medicine|September 10, 2024
Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe HypoxemiaMagnus Ekström, Anders Andersson, Savvas Papadopoulos, et al.Cardiovascular Research|August 7, 2019
Palliative care for people living with heart failure: European Association for Palliative Care Task Force expert position statementPiotr Z Sobanski, Bernd Alt-Epping, David C Currow, et al.BMJ Open|February 8, 2022
Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocolHiromichi Matsuoka, Katherine Clark, Belinda Fazekas, et al.Journal of Pain and Symptom Management|April 15, 2014
An analytical framework for delirium research in palliative care settings: integrated epidemiologic, clinician-researcher, and knowledge user perspectivesPeter G Lawlor, Daniel H J Davis, Mohammed Ansari, et al.Pageof 43